Beyond Air, Inc.
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 13, 2026
XAIR$2.52+10.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(amounts in thousands)
| For the Three Months Ended | ||||
|---|---|---|---|---|
| June 30, | ||||
| 2026 · 2025 | ||||
| Cash flows from operating activities | ||||
| Net loss | $(8,154) | $(8,078) | ||
| Adjustments to reconcile net loss to net cash used in operating activities | ||||
| Depreciation | 746 | 754 | ||
| Amortization of licensed right to use technology | 51 | 51 | ||
| Stock-based compensation | 1,036 | 1,577 | ||
| Amortization of debt discount and accretion of debt issuance costs | 431 | 54 | ||
| Change in fair value of warrant liability | (1) | (17) | ||
| Amortization of operating lease assets | 123 | 121 | ||
| Paid in kind interest | 484 | 389 | ||
| Provision for inventory losses | 22 | 104 | ||
| Provision for bad debt | 91 | - | ||
| Foreign currency adjustments | 3 | (128) | ||
| Loss on extinguishment of debt | 153 | - | ||
| Loss on disposal of fixed assets | 52 | 11 | ||
| Unrealized (gain)/loss on marketable securities | 2 | (9) | ||
| Changes in: | ||||
| Inventory | 196 | 188 | ||
| Accounts receivable | (145) | (94) | ||
| Other current assets and prepaid expenses | (196) | 617 | ||
| Accounts payable | (321) | (708) | ||
| Accrued expenses | 625 | 691 | ||
| Operating lease liabilities | (144) | (49) | ||
| Net cash used in operating activities | (4,946) | (4,526) | ||
| Cash flows from investing activities | ||||
| Purchase of marketable securities | (40) | (3) | ||
| Proceeds from sale of marketable securities | 637 | 777 | ||
| Security deposits from leases | 72 | - | ||
| Purchase of property and equipment | (208) | (198) | ||
| Net cash provided by investing activities | 461 | 576 | ||
| Cash flows from financing activities | ||||
| Proceeds from issuance of common stock through at the market offerings | - | 2,441 | ||
| Proceeds from NeuroNos investment | 3,228 | - | ||
| Proceeds from long term loan | - | 2,000 | ||
| Payment of loans | (170) | (375) | ||
| Net cash provided by financing activities | 3,058 | 4,066 | ||
| Effect of exchange rate changes on cash and cash equivalents | (21) | 127 | ||
| Increase/(decrease) in cash, cash equivalents and restricted cash | (1,448) | 243 | ||
| Cash, cash equivalents and restricted cash at beginning of period | 12,362 | 4,896 | ||
| Cash, cash equivalents and restricted cash at end of period | $10,914 | $5,139 | ||
| Supplemental disclosure of non-cash investing and financing activities | ||||
| Conversion of debt principal balance to equity | $500 | $ | - | |
| Fixed assets included in accounts payable and accrued expenses | $361 | $ | - | |
| Supplemental disclosure of cash flow items: | ||||
| Interest paid | $116 | $96 | ||
| Income taxes paid | $ | - | $ | - |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.